Trade policy and the politics of access to drugs

Third World Quarterly

Volumn 23, Issue 2, 2002, Pages 251-264

  Thomas, Caroline ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSIBILITY; DRUG PRESCRIBING; HEALTH POLICY; TRADE POLICY; WORLD TRADE ORGANIZATION;

EID: 0036117884     PISSN: 01436597     EISSN: None     Source Type: Journal    
DOI: 10.1080/01436590220126621     Document Type: Article

References (37)

1. Africa Trade Bill: Clinton issues Executive Order relaxing intellectual property rights
2. Globalization and international trade in the twenty-first century: Opportunities for and threats to the health sector in the South
3. Globalization, pharmaceutical pricing, and South African health policy: Managing confrontation with US firms and politicians
4. The consequences of pharmaceutical product patenting
5. Ensuring access in developing countries
6. An unequal calculus of life and death
7. Africa treatment access in the news
8. Compulsory licensing for bridging the gap - Treatment access in developing countries: Interview with James love, consumer project on technology
9. Africa: Southern countries lack infrastructure to accept offer of price cuts for AIDS drugs
10. Healthy public policy and the WTO: A proposal for an international health presence in future trade/investment talks
11. Global issues of access to pharmaceuticals and effects of patents
12. Patents and pharmaceutical drugs: Understanding the pressures on developing countries
13. For MSF access to fluconazole in less-developed countries
14. Glaxo attempts to block access to generic AIDS drugs in Ghana
15. Drug majors battle for Ghana's AIDS market
16. The World Bank: Friend or foe?
17. Drug firms fight lamy
18. WHO calls for third world medical research